Literature DB >> 18190458

Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.

M C Pickering1, H T Cook.   

Abstract

Factor H is the major regulatory protein of the alternative pathway of complement activation. Abnormalities in factor H have been associated with renal disease, namely glomerulonephritis with C3 deposition including membranoproliferative glomerulonephritis (MPGN) and the atypical haemolytic uraemic syndrome (aHUS). Furthermore, a common factor H polymorphism has been identified as a risk factor for the development of age-related macular degeneration. These associations suggest that alternative pathway dysregulation is a common feature in the pathogenesis of these conditions. However, with respect to factor H-associated renal disease, it is now clear that distinct molecular defects in the protein underlie the pathogenesis of glomerulonephritis and HUS. In this paper we review the associations between human factor H dysfunction and renal disease and explore how observations in both spontaneous and engineered animal models of factor H dysfunction have contributed to our understanding of the pathogenesis of factor H-related renal disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18190458      PMCID: PMC2276951          DOI: 10.1111/j.1365-2249.2007.03574.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  107 in total

1.  Secondary membranoproliferative glomerulonephritis.

Authors:  H G Rennke
Journal:  Kidney Int       Date:  1995-02       Impact factor: 10.612

2.  Complement C3 gene expression and regulation in human glomerular epithelial cells.

Authors:  S H Sacks; W Zhou; A Pani; R D Campbell; J Martin
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

3.  Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease).

Authors:  J H Jansen; K Høgåsen; T E Mollnes
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

Review 4.  Hereditary complement factor I deficiency.

Authors:  T J Vyse; P J Späth; K A Davies; B J Morley; P Philippe; P Athanassiou; C M Giles; M J Walport
Journal:  QJM       Date:  1994-07

5.  Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-gamma.

Authors:  M E van den Dobbelsteen; V Verhasselt; J G Kaashoek; J J Timmerman; W E Schroeijers; C L Verweij; F J van der Woude; L A van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

6.  C3 and C4 gene expression and interferon-gamma-mediated regulation in human glomerular mesangial cells.

Authors:  S Sacks; W Zhou; R D Campbell; J Martin
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

7.  Familial hemolytic-uremic syndrome and homozygous factor H deficiency.

Authors:  V Pichette; S Quérin; W Schürch; G Brun; G Lehner-Netsch; J M Delâge
Journal:  Am J Kidney Dis       Date:  1994-12       Impact factor: 8.860

8.  Human complement factor H. Tissue specificity in the expression of three different mRNA species.

Authors:  W Schwaeble; H Schwaiger; R A Brooimans; A Barbieri; J Möst; M Hirsch-Kauffmann; M Tiefenthaler; D F Lappin; M R Daha; K Whaley
Journal:  Eur J Biochem       Date:  1991-06-01

9.  Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency.

Authors:  K Høgåsen; J H Jansen; T E Mollnes; J Hovdenes; M Harboe
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

10.  Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis.

Authors:  S Meri; V Koistinen; A Miettinen; T Törnroth; I J Seppälä
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

View more
  78 in total

Review 1.  Animal models of age related macular degeneration.

Authors:  Mark E Pennesi; Martha Neuringer; Robert J Courtney
Journal:  Mol Aspects Med       Date:  2012-06-15

Review 2.  C3 glomerulopathy: a new classification.

Authors:  Fadi Fakhouri; Véronique Frémeaux-Bacchi; Laure-Hélène Noël; H Terence Cook; Matthew C Pickering
Journal:  Nat Rev Nephrol       Date:  2010-07-06       Impact factor: 28.314

Review 3.  Complement control protein factor H: the good, the bad, and the inadequate.

Authors:  Viviana P Ferreira; Michael K Pangburn; Claudio Cortés
Journal:  Mol Immunol       Date:  2010-08       Impact factor: 4.407

4.  Complement activation in leprosy: a retrospective study shows elevated circulating terminal complement complex in reactional leprosy.

Authors:  N Bahia El Idrissi; S Hakobyan; V Ramaglia; A Geluk; B Paul Morgan; P Kumar Das; F Baas
Journal:  Clin Exp Immunol       Date:  2016-03-31       Impact factor: 4.330

Review 5.  Factor I and factor H deficiency in renal diseases: similar defects in the fluid phase have a different outcome at the surface of the glomerular basement membrane.

Authors:  Peter F Zipfel; Richard J H Smith; Christine Skerka
Journal:  Nephrol Dial Transplant       Date:  2008-12-04       Impact factor: 5.992

Review 6.  Therapeutic potential of complement modulation.

Authors:  Eric Wagner; Michael M Frank
Journal:  Nat Rev Drug Discov       Date:  2009-12-04       Impact factor: 84.694

Review 7.  C3 Glomerulopathy.

Authors:  Magdalena Riedl; Paul Thorner; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2016-04-07       Impact factor: 3.714

Review 8.  CD46 in innate and adaptive immunity: an update.

Authors:  J Cardone; G Le Friec; C Kemper
Journal:  Clin Exp Immunol       Date:  2011-04-13       Impact factor: 4.330

9.  Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis.

Authors:  Daniel P Gale; Elena Goicoechea de Jorge; H Terence Cook; Rubén Martinez-Barricarte; Andreas Hadjisavvas; Adam G McLean; Charles D Pusey; Alkis Pierides; Kyriacos Kyriacou; Yiannis Athanasiou; Konstantinos Voskarides; Constantinos Deltas; Andrew Palmer; Véronique Frémeaux-Bacchi; Santiago Rodriguez de Cordoba; Patrick H Maxwell; Matthew C Pickering
Journal:  Lancet       Date:  2010-08-25       Impact factor: 79.321

Review 10.  aHUS caused by complement dysregulation: new therapies on the horizon.

Authors:  Aoife M Waters; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2010-06-18       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.